108 related articles for article (PubMed ID: 2074244)
1. An open multicentre study of the efficacy and tolerance of cefodizime 1 g bd intravenously or intramuscularly in lower respiratory tract infections.
Sollet JP
J Antimicrob Chemother; 1990 Nov; 26 Suppl C():103-10. PubMed ID: 2074244
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and tolerance of cefodizime in the treatment of acute pyelonephritis.
Kourilsky O
J Antimicrob Chemother; 1990 Nov; 26 Suppl C():111-6. PubMed ID: 2074245
[TBL] [Abstract][Full Text] [Related]
3. Cefodizime once daily in the treatment of lower respiratory tract infections.
Piovano CF; Palombini BC; Dagrosa EE; Mendoza F; Facco EB
Arzneimittelforschung; 1997 May; 47(5):674-7. PubMed ID: 9205786
[TBL] [Abstract][Full Text] [Related]
4. Cefodizime given in single or divided doses for the treatment of lower respiratory tract infection.
Palombini BC; André-Alves MR; Dagrosa EE
Arzneimittelforschung; 1997 Mar; 47(3):299-302. PubMed ID: 9105549
[TBL] [Abstract][Full Text] [Related]
5. A randomized, dose comparison study of cefodizime in the treatment of lower urinary tract infections in women.
Asbach HW
Infection; 1991; 19(2):85-7. PubMed ID: 2050425
[TBL] [Abstract][Full Text] [Related]
6. Cefodizime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
Barradell LB; Brogden RN
Drugs; 1992 Nov; 44(5):800-34. PubMed ID: 1280568
[TBL] [Abstract][Full Text] [Related]
7. Clinical safety profile of cefodizime.
Perianu MR
J Antimicrob Chemother; 1990 Nov; 26 Suppl C():127-34. PubMed ID: 2074247
[TBL] [Abstract][Full Text] [Related]
8. Review of effectiveness of cefodizime in the treatment of lower respiratory tract infections with parenchymal involvement.
Pauwels RA
Infection; 1992; 20 Suppl 1():S26-30. PubMed ID: 1526672
[TBL] [Abstract][Full Text] [Related]
9. [Pharmacokinetic and clinical studies on cefodizime in the pediatric field. Pediatric Study Group of Cefodizime].
Fujii R; Arimasu O; Meguro H; Hiruma F; Sugie N; Abe T; Nakazawa S; Sato H; Narita A; Matsumoto K
Jpn J Antibiot; 1989 May; 42(5):1173-93. PubMed ID: 2664256
[TBL] [Abstract][Full Text] [Related]
10. Single daily dose of cefodizime in patients with community-acquired pneumonia: an open-label, controlled, randomized study. The Italian Multicentre Community-Acquired Pneumonia Group.
De Palma M; Rocchi D; Canepa G; Peri A; Cantone V
Clin Ther; 1995; 17(3):413-24. PubMed ID: 7585845
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of ceftizoxime administered twice daily in hospitalized patients with respiratory tract infections.
Lentnek A; Wikler M; McDevitt J; Sohn C
Clin Ther; 1984; 7(1):33-9. PubMed ID: 6097357
[TBL] [Abstract][Full Text] [Related]
12. [A comparative study between cefodizime (CDZM) and cefotaxime (CTX) in respiratory tract infections].
Takebe K; Imamura K; Masuda M; Murakami S; Tomiyama M; Tamura T; Endou K; Ishimaru K; Okushima T; Nakazono M
Kansenshogaku Zasshi; 1989 Apr; 63(4):318-51. PubMed ID: 2506292
[TBL] [Abstract][Full Text] [Related]
13. Cefepime versus cefotaxime in the treatment of lower respiratory tract infections.
Barckow D; Schwigon CD
J Antimicrob Chemother; 1993 Nov; 32 Suppl B():187-93. PubMed ID: 8150762
[TBL] [Abstract][Full Text] [Related]
14. Randomized comparative study of 0.5 and 1 g of cefodizime (HR 221) versus 1 g of cefotaxime for acute uncomplicated urogenital gonorrhea.
van der Willigen AH; Wagenvoort JH; Schalla WO; Knapp JS; Boot JM; Heeres-Weststrate PL; Michel MF; van Klingeren B; Stolz E
Antimicrob Agents Chemother; 1988 Apr; 32(4):426-9. PubMed ID: 3377456
[TBL] [Abstract][Full Text] [Related]
15. [Bacteriological and clinical studies of cefodizime in pediatrics].
Akita H; Sato Y; Iwata S; Sunakawa K
Jpn J Antibiot; 1991 Apr; 44(4):398-411. PubMed ID: 1880919
[TBL] [Abstract][Full Text] [Related]
16. [Clinical experience with cefodizime in pediatric field].
Sekiguchi T; Okamoto T; Ohara K; Kouzan H; Nishimori M; Miyazaki M
Jpn J Antibiot; 1989 Jun; 42(6):1391-8. PubMed ID: 2795863
[TBL] [Abstract][Full Text] [Related]
17. Cefodizime in clinical use: a review of the clinical trial reports.
Grassi GG
J Antimicrob Chemother; 1990 Nov; 26 Suppl C():117-25. PubMed ID: 2074246
[TBL] [Abstract][Full Text] [Related]
18. Clinical evaluation of cefotiam and cefamandole in respiratory tract infections.
Beumer HM; Olislagers WP; Kahn M; van Hamersveld JD
Int J Clin Pharmacol Ther Toxicol; 1985 Feb; 23(2):105-8. PubMed ID: 3886564
[TBL] [Abstract][Full Text] [Related]
19. [Clinical studies of cefodizime in the pediatric field].
Niino M; Kida K; Matsuda H; Murase M
Jpn J Antibiot; 1989 Jun; 42(6):1400-13. PubMed ID: 2795864
[TBL] [Abstract][Full Text] [Related]
20. Cefodizime (HR221) versus norfloxacin for treatment of urinary tract infections.
Esposito S; Sardaro C; Gaeta GB; Galante D; Giusti G; Basani F
J Chemother; 1991 Feb; 3(1):42-4. PubMed ID: 2019862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
